Clinical Trial Update: Safety and Tolerability of ToleroMune Grass in Grass Allergic Subjects With Rhinoconjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety and tolerability of ToleroMune Grass in individuals with grass pollen–induced allergic rhinitis (rhinoconjunctivitis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• ToleroMune Grass

Snippet

Sponsor: Circassia Limited | Conditions: Allergy | Phase 2 | Status: COMPLETED